Microsite Matches Oncology Sponsors with Canadian Investigators
Scimega Research, an oncology-focused CRO, has launched its new Reverse Feasibility Resource Center
Scimega Research, (www.scimega.com) an oncology-focused CRO, has launched its new Reverse Feasibility Resource Center, that is aimed at matching U.S. oncology sponsors in need of Canadian investigators and their patients.
This microsite will be updated regularly to highlight Canada’s expertise in both early and late phase oncology trials. It currently features important information such as the number of oncology sites, key investigators, and the size of the catchment areas for each of the ten Canadian provinces. Sponsors can sign up to receive free quarterly updates on the types of trials Scimega’s Reverse Feasibility Champions are looking to participate in. This Oncology Trial Needs Report for Canada will highlight the number of sites actively looking for a trial, including lines of treatment, tumor types and targets.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
